Skip to content

Clinical trials

Phase 4 Hemorrhage trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 4 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20151
20173
20182
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Academy of Medical Sciences, Fuwai Hospital3
Xijing Hospital2
Beijing Tiantan Hospital1
China National Center for Cardiovascular Diseases1
Ethicon, Inc.1
Peking Union Medical College Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai Zhongshan Hospital1
Shenyang Northern Hospital1
Wuhan Asia Heart Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage14
Myocardial Infarction4
Stroke3
Cardiovascular Diseases2
Embolism and Thrombosis2
Liver Cirrhosis2
Mitral Valve Insufficiency2
Angina Pectoris1
Cerebral Hemorrhage1
Coronary Artery Disease1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.